← Eichor
Study identifier: NCT07600957 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Polarized Light Therapy for Radiation Dermatitis in Breast Cancer

Condition: Radio Dermatitis · Polarized Light · Breast Cancer Survivors  ·  Sponsor: Beni-Suef University

PhaseNA
Planned participants60
Who can joinFemale, 35 Years to 55 Years
Healthy volunteersNo

About this study

This assessor-blinded randomized controlled trial aims to evaluate the efficacy of polarized polychromatic non-coherent light therapy as an adjunct to standard skin care in reducing acute radiation dermatitis in women with breast cancer undergoing hypofractionated whole-breast radiotherapy. Participants will be randomly allocated to receive either standard skin care alone or standard care combined with polarized light therapy initiated from the first radiotherapy session. Outcomes will include objective ultrasound-based dermal thickness measurements, clinical severity of radiation dermatitis using Radiation Therapy Oncology Group (RTOG) criteria.

This description comes directly from the study's public registry record.

Talk to the study team

Marwa Elsayed Mohamed Lecturer, Ph.D  ·  01141825442  ·  Marwa.elsayed@pt.bsu.edu.eg

Always discuss trial participation with your own doctor first.

Locations (1)

Out patient clinic , faculty of Physical Therapy, Beni Sueif universityBanī Suwayf, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07600957